CST BLOG: Lab Expectations

The official blog of Cell Signaling Technology (CST) where we discuss what to expect from your time at the bench, share tips, tricks, and information.

Lab Expectations listing page

Read More

Amrik Singh, PhD

Amrik Singh, PhD

Amrik Singh is an Immunology Fellow at Cell Signaling Technology. He is a biochemist trained at Boston University Medical Center and Beth Israel Deaconess Medical Center. At CST, he is helping to develop and manage the adoptive cell therapy product portfolio with a specific interest in developing antibodies and assays to characterize CAR-T cells.

Recent Posts:

Anti-CAR Linker mAbs: First-to-Market CAR Detection Reagents for CAR-T Therapy

CST® anti-CAR linker antibodies won The Innovation Award from CiteAb in 2023. Read on to learn why! ...
Amrik Singh, PhD Nov 8, 2022

Targeting B-Cell Maturation Antigen (BCMA) Holds Promise for Multiple Myeloma Cure

Multiple myeloma (MM) is a type of hematopoietic malignancy characterized, in part, by bone pain, an...
Amrik Singh, PhD Aug 8, 2018

GPNMB: A Promising Immunotherapeutic Target for Triple Negative Breast Cancer

The last few years have witnessed several breakthroughs in the immuno-oncology space. Treatments tha...
Amrik Singh, PhD Apr 4, 2018

    Related Posts